Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ekta Mukhopadhyay


Postdoctoral Researcher in Mucosal Immunology

I am a Post- Doctoral Researcher in mucosal immunology working on pre-clinical evaluation of oral vaccines. I have been involved in vaccine research working on adenoviral (ChAd63 and ChAdOx1) and Virus-like particle vaccines (R21) for infectious diseases like malaria, HIV, influenza and zika. My past experience of working on process development, production and quality assessment of these vaccines made me curious about pre-clinical vaccine development which I was able to study during my DPhil in Clinical Medicine at the Jenner Institute. I have been a part of the Clinical Biomanufacturing Facility team and involved in process development and production of the first batch of the R21 vaccine for the Phase I clinical trial that has now advanced into Phase III trials.

During my DPhil, I have explored and assessed new malaria vaccine candidates for immunogenicity and efficacy that have provided promising results to progress into clinical trials. I have also investigated into alternative vaccination strategies and exploring glycans as malaria vaccine candidates. During this time, I got an opportunity to be a part of the Oxford/AZ ChAdOx1 nCov-19 coronavirus vaccine and R21 vaccine clinical trials.



Recent publications

More publications